| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8773848 | Kidney International Reports | 2018 | 7 Pages |
Abstract
The incidence of ESKD from scleroderma appears to have declined in the United States since 1996. ESKD from scleroderma is associated with an enhanced likelihood of recovery of kidney function and death, a reduced likelihood of transplantation, and similar outcomes after transplantation.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Donal J. Sexton, Scott Reule, Robert N. Foley,